[1\]Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond\[J\]. Nat Rev Cancer，2010， 10(6): 403-414.\[2\]Salama NR, Hartung ML, Müller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori\[J\]. Nat Rev Microbiol，2013，11(6): 385-399.\[3\]Backert S, Selbach M. Role of type Ⅳ secretion in Helicobacter pylori pathogenesis\[J\]. Cell Microbiol，2008，10(8): 1573-1581.\[4\]Tegtmeyer N, Wessler S, Backert S. Role of the cagpathogenicity island encoded type Ⅳ secretion system in Helicobacter pylori pathogenesis\[J\]. FEBS J,2011, 278(8): 1190-1202.\[5\]De Bernard M, Josenhans C. Pathogenesis of Helicobacter pylori infection\[J\]. Helicobacter,2014, 19 (Suppl 1): 11-18.\[6\]Sugiyama T,Asaka M.Helicobacter pylori infection and gastric cancer\[J\]. Med Electron Microsc,2004, 37(3): 149-157.\[7\]Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein\[J\]. Nat Rev Cancer, 2004,4(9): 688-694.\[8\]Franco AT, Israel DA, Washington MK, et al. Activation of βcatenin by carcinogenic Helicobacter pylori\[J\]. Proc Natl Acad Sci U S A, 2005,102(30): 10646-10651.\[9\]Gwack J, Shin A, Kim CS, et al. CagAproducing Helicobacter pylori and increased risk of gastric cancer: a nested casecontrol study in Korea\[J\]. Br J Cancer,2006, 95(5): 639-641.\[10\]Brandt S, Kwok T, Hartig R, et al. NFκB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein\[J\]. Proc Natl Acad Sci U S A, 2005, 102(26): 9300-9305.\[11\]Queiroz DM, Harris PR, Sanderson IR,et al. Iron status and Helicobacter pylori infection in symptomatic children: an international multicentered study\[J\]. PLoS One,2013,8(7): e68833.\[12\]McColl KE. Clinical practice. Helicobacter pylori infection\[J\]. N Engl J Med, 2010, 362(17): 1597-1604.\[13\]van Doorn LJ, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori\[J\]. Gastroenterology,1998, 115(1): 58-66.\[14\]Plummer M, van Doorn LJ, Franceschi S,et al. Helicobacter pylori cytotoxinassociated genotype and gastric precancerous lesions\[J\]. J Natl Cancer Inst, 2007, 99(17): 1328-1334.\[15\]Franco AT, Johnston E, Krishna U, et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors\[J\]. Cancer Res, 2008, 68(2): 379-387.\[16\]Franco AT, Israel DA, Washington MK, et al. Activation of βcatenin by carcinogenic Helicobacter pylori\[J\]. Proc Natl Acad Sci U S A, 2005,102(30): 10646-10651.\[17\]Wang X, Ling F, Wang H,et al.The Helicobacter pylori Cag pathogenicity island protein Cag1 is associated with the function of T4SS\[J\]. Curr Microbiol, 2016,73(1): 22-30.\[18\]Zhong Q, Shao S, Mu R, et al. Characterization of peptidoglycan hydrolase in Cag pathogenicity island of Helicobacter pylori\[J\]. Mol Biol Rep, 2011, 38(1): 503-509.\[19\]Ling F, Wang X, Dai D, et al. The Helicobacter pylori protein CagM is located in the transmembrane channel that is required for CagA translocation\[J\]. Curr Microbiol, 2013, 67(5): 531-536.\[20\]Li N, Xu X, Xiao B, et al. H. pylori related proinflammatory cytokines contribute to the induction of miR146a in human gastric epithelial cells\[J\]. Mol Biol Rep,2012,39(4): 4655-4661.\[21\]Liu Z, Xiao B, Tang B, et al. Upregulated microRNA146a negatively modulate Helicobacter pyloriinduced inflammatory response in human gastric epithelial cells\[J\]. Microbes Infect,2010,12(11): 854-863.\[22\]Tang B, Xiao B, Liu Z, et al. Identification of MyD88 as a novel target of miR155, involved in negative regulation of Helicobacter pyloriinduced inflammation\[J\]. FEBS Lett,2010,584(8): 1481-1486.
2017, Vol. 27 
